This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma | MicrobiomeTrials

NCT03264131

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2018-10-11Est. Completion: 2023-12-15

Enrollment target: 16 participants

Locations

South Broward/Memorial Healthcare System, Hollywood, Florida, United States
Boston Medical Center, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, United States
Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Lymphoma

The purpose of this study is to evaluate the safety and efficacy of lisocabtagene maraleucel (Breyanzi/liso-cel/BMS-9863…

Aurora, United StatesEst. completion Jan 9, 2028

Hematologic Malignancies

SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and an…

Birmingham, United StatesEst. completion Dec 30, 2026

Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

This phase I trial tests the safety, side effects, best dose and effectiveness of lenalidomide when added to nivolumab a…

Los Angeles, United StatesEst. completion Apr 1, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.